Procyon Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Sell
1,449
-58
-4% -$15.2K 0.02% 399
2026
Q1
$402K Buy
1,507
+633
+72% +$171K 0.02% 389
2025
Q4
$219K Sell
874
-114
-12% -$30.3K 0.01% 506
2025
Q3
$284K Buy
988
+57
+6% +$15.3K 0.02% 416
2025
Q2
$244K Buy
931
+55
+6% +$13.4K 0.02% 416
2025
Q1
$204K Buy
+876
New +$213K 0.01% 567
2020
Q3
Sell
-158
Closed -$23K 673
2020
Q2
$23K Buy
158
+18
+13% +$2.49K 0.01% 519
2020
Q1
$15K Buy
140
+75
+115% +$10.8K 0.01% 525
2019
Q4
$9K Buy
+65
New +$9.38K 0.01% 686

Other funds holding LH

Procyon Advisors's LH Position: Q2 2026 in Review

Procyon Advisors reduced its Labcorp (LH) stake by 3.8% in Q2 2026, selling an estimated $15.2K and leaving 1,449 shares worth $406K. The position accounts for 0.02% of the portfolio, ranked #399.

Procyon Advisors first reported a position in LH in Q4 2019 and has held it in 9 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Procyon Advisors held 1,449 shares of Labcorp worth $406K as of Q2 2026.
  • Procyon Advisors sold 58 Labcorp shares in Q2 2026, an estimated $15.2K.
  • Labcorp made up 0.02% of Procyon Advisors's portfolio in Q2 2026, its #399 holding.
  • Procyon Advisors first reported a position in Labcorp in Q4 2019 and has held it in 9 quarters since.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.